- Alternative title
-
JAK Inhibitors for the Treatment of Haemato-Oncological Diseases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Bibliographic citation
-
JAK-Inhibitoren für die Behandlung hämatoonkologischer Erkrankungen ; volume:45 ; number:06 ; year:2020 ; pages:559-567
Aktuelle Rheumatologie ; 45, Heft 06 (2020), 559-567
- Keyword
-
Inhibitor
Krankheit
Osteomyelofibrose
Polycythaemia rubra vera
Patient
- Contributor
-
Steinbrunn, Torsten
Zovko, Josip
Kraus, Sabrina
- DOI
-
10.1055/a-1285-4125
- URN
-
urn:nbn:de:101:1-2021021111294580351881
- Rights
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Steinbrunn, Torsten
- Zovko, Josip
- Kraus, Sabrina
Other Objects (12)
Charakterisierung und Untersuchung neuer JAK-Inhibitoren zur Behandlung chronisch entzündlicher Darmerkrankungen
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Synthesis of pan-JAK Inhibitor PF-06263276
Stellenwert der JAK-Inhibitoren („small is beautiful“)
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
Macrophage re-programming by JAK inhibitors relies on MAFB
Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
Small Molecule Inhibitors of Interferon‐Induced JAK‐STAT Signalling
Small Molecule Inhibitors of Interferon‐Induced JAK‐STAT Signalling
Charakterisierung und Untersuchung neuer JAK-Inhibitoren zur Behandlung chronisch entzündlicher Darmerkrankungen
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Synthesis of pan-JAK Inhibitor PF-06263276
Stellenwert der JAK-Inhibitoren („small is beautiful“)
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
Macrophage re-programming by JAK inhibitors relies on MAFB
Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
Small Molecule Inhibitors of Interferon‐Induced JAK‐STAT Signalling
Small Molecule Inhibitors of Interferon‐Induced JAK‐STAT Signalling
Charakterisierung und Untersuchung neuer JAK-Inhibitoren zur Behandlung chronisch entzündlicher Darmerkrankungen
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Synthesis of pan-JAK Inhibitor PF-06263276
Stellenwert der JAK-Inhibitoren („small is beautiful“)
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
Macrophage re-programming by JAK inhibitors relies on MAFB
Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
Small Molecule Inhibitors of Interferon‐Induced JAK‐STAT Signalling